Chongkundang Holdings Corp (001630) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Chongkundang Holdings Corp (001630:KRX), powered by AI.

Current Price
₩41,200
P/E Ratio
5.1
Market Cap
206.4B
Sector
Healthcare
What is the Chongkundang Holdings Corp stock price forecast?

Chongkundang Holdings Corp is currently trading at ₩41,200. View real-time AI analysis on Alpha Lenz.

What is Chongkundang Holdings Corp insider trading activity?

View the latest insider trading data for Chongkundang Holdings Corp on Alpha Lenz.

What is Chongkundang Holdings Corp's P/E ratio?

Chongkundang Holdings Corp's P/E ratio is 5.1.

Chongkundang Holdings Corp

KRX · 001630
₩41,200-350(-0.84%)Market closedKRX regular session 09:00–15:30 KST
Ask about Chongkundang Holdings Corp's future dividend policy...
Alpha Chat Insight

Chongkundang Holdings Corp trades at a P/E of 5.1 (undervalued) with modest ROE of 6.6%.

Ask for details

Company Overview

Chongkundang Holdings Corp is a prominent holding company based in South Korea. Its primary function is to manage and oversee its various subsidiary companies, which operate predominantly in the pharmaceutical and health-related sectors. As a holding entity, Chongkundang Holdings Corp provides strategic guidance and financial oversight to its subsidiaries, facilitating operational efficiency and growth. The company's influence extends into diverse industries, often focusing on innovative healthcare solutions, manufacturing of pharmaceuticals, and distribution of medical supplies. This wide-ranging involvement makes Chongkundang Holdings Corp significant in the South Korean financial market, as it aligns with the growing global demand for medical and healthcare advancements. Its role as a holding company positions it as a cornerstone for fostering innovation within its subsidiaries, at the same time impacting broader industry standards and practices.

CEO최희남
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees37

Company Statistics

FY 2025

Profile

₩206,406,273,200Market Cap
₩959,011,774,430Revenue
5.01MShares Out
37Employees

Margins

44.56%Gross
13.08%EBITDA
6.08%Operating
6.79%Pre-Tax
5.66%Net

Valuation

5.11P/E
0.32P/B
0.22EV/Sales
7.52EV/EBITDA
11.22P/FCF

Growth (CAGR)

1.80%Rev 3Yr
2.25%Rev 5Yr
N/AOp Inc 3Yr
-8.17%Op Inc 5Yr
N/ANet Inc 3Yr
-13.72%Net Inc 5Yr

Returns

3.48%ROA
6.60%ROE
5.49%ROIC

Financial Health

₩80,333,473,720Cash & Cash Equivalents
₩635,391,913,240Net Debt
78.39%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Chongkundang Holdings Corp (ticker: 001630) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 37 employees. Market cap is $206.4B.

The current price is ₩41,200 with a P/E ratio of 5.11x and P/B of 0.32x.

ROE is 6.60% and operating margin is 6.08%. Annual revenue is $959.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Chongkundang Holdings Corp (001630) Stock Forecast 2026 ₩41,200 — Price, Financials & Analyst Targets | Alpha Lenz